Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

ACS CAN Cancer Policy Priorities: New Mexico Society of Clinical Oncology Oct. 8, 2022 Brian Hummell, AZ/NM Director of Govt. Relations Brian.hummell@cancer.org Disclosure of Conflicts of Interest Brian Hummell has no relevant financial relationships to disclose. Cancer burden in New Mexico According to ACS Cancer Facts & Figures 2022 11,030 New Mexicans will be …
PowerPoint Presentation New Mexico Society of Clinical Oncology 2022 • Jeffrey N. Weitzel, M.D. • Professor, Latin American School of Oncology • VP Medical Affairs Hereditary Cancer, Natera Cancer Genetics: A Vision for Precision DISCLOSURE OF CONFLICTS OF INTEREST Jeffrey N. Weitzel, M.D. has the following financial relationships to disclose: • Employee, Natera • …
Identifying and Managing Cancer Treatment Cardiotoxicities in Patients Undergoing Therapy Michel G. Khouri, MD Associate Professor of Medicine Division of Cardiology Duke University Health System 2 • Apply evidence-based approaches to identify and assess patients at risk for cardiotoxicity • Discuss the use of clinical tools, imaging, and other tests to evaluate patients at risk …
NYOH Draft Flyer WEDNESDAY OCT. 12 | 2 P.M. WEST CAPITOL PARK ALBANY, NY SAVE OUR ACCESS, SAVE OUR LIVES The New York State Department of Health (NYDOH) made a policy change to their Medicaid Pharmacy Program that prevents Medicaid patients from obtaining their oral medication through their physician dispensary. This forces patients to receive their oral cancer medication prescriptions …
While remote monitoring platforms have been used effectively throughout the COVID-19 pandemic to reduce the burden on patients and healthcare facilities around the country, Vanderbilt Ingram Cancer Center in Nashville, Tenn., has been using the technology in a different capacity—with its chimeric antigen receptor (CAR) T-cell therapy patients.
ACCCBuzz shares highlights from the NCCN Policy Summit: Reducing the Cancer Burden through Prevention and Early Detection, highlighting the real impacts felt by patients and providers in cancer risk identification and reduction.
State legislation across the U.S. is tackling health insurance coverage for comprehensive biomarker testing. Learn more about what's going on where you live and across the nation.
Hear how to educate patients and their caregivers about the risks and benefits to oral therapies for breast cancer.
September 28, 2022 The Honorable Nancy Pelosi The Honorable Kevin McCarthy Speaker Republican Leader U.S. House of Representatives U.S. House of Representatives H-232, The Capitol H-204, The Capitol Washington, DC 20515 Washington, DC 20515 The Honorable Charles …
Recognizing the good work done within a healthcare organization can have a highly positive impact on team morale and productivity. Thus leaders should strive to recognize the work of their staff.
MD Anderson Ishwaria M. Subbiah, MD, MS Associate Professor, Department of Palliative, Rehabilitation & Integrative Medicine Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston, TX PROS vs CONS OF SOCIAL MEDIA USE FOR HEALTHCARE PROFESSIONALS I s h w a r i a S u b b i a h , M D M S - - Tw i t t e r : i s h w a r i a M D - - i s u b b i a h @ m …
In a letter to congressional leadership, ACCC joined 16 other healthcare associations and coalitions urging Congress to extend Medicare's 5 percent advanced alternative payment model (APM) incentive payments in an end-of-year legislative package. Originally authorized under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), these incentive payments were intended to support providers …
Exercise and Diet in Cancer Patients: Current Guidelines Carolyn M. Matthews, MD October 2022 Disclosure of Conflicts of Interest Carolyn M. Matthews, MD, has no relevant financial relationships to disclose. Role of Nutrition in Oncology Community interest Oncologist Research Prevention/treatment/survivorship Overweight/obesity Cancer causation …
ACCCBuzz spoke with Dr. Dan Vogl to learn more about the treatment options available to patients with multiple myeloma, including the benefits of adding anti-CD38 monoclonal antibodies in either first- or second-line treatment.
ACCC—the how-to organiza- tion for the multidisciplinary cancer care team— has a long and rich history of bringing forward technology- driven solutions. More than a decade ago in 2011, ACCC created its Innovator Award program to recognize visionary ideas and compelling solutions in oncology. MultiCare Health System, MultiCare Regional Cancer Center was recognized for leveraging technology …
September 28, 2022
Motif Seattle 1415 5th Ave. Seattle, WA 98101 206.971.8000 Join the Montana State Oncology Society for a comprehensive update on solid tumors and hematologic disorders at the Fred Hutchinson Cancer Center 13th Annual Comprehensive Hematology & Oncology Review Course. This accredited, multi-day, in-person program will cover data supporting guidelines, recommendations, and recent advances regarding …
Technological solutions can be used to identify and mitigate the effects of health disparities, helping clinicians understand the factors that affect care delivery.
Microsoft Word - Harrisburg- PA ORM Agenda.docx Harrisburg, PA, Fall ORM Agenda 9:00 – 9:45 AM EST Breakfast 9:45 – 10:30 AM EST Welcome and ACCC Policy Update Matt Devino, MPH, Director of Cancer Care Delivery & Health Policy Association of Community Cancer Centers With the release of the proposed Hospital Outpatient Prospective Payment System and Medicare Physician Fee …
Understanding Immune Suppression in Pancreas Cancer: A Key Role for Gamma Delta T Cells Johnathan Ebben, MD, PhD Oncology Fellow, University of Wisconsin- Madison Carbone Cancer Center WAHO 2022 Annual Conference Disclosure of Conflicts of Interest Johnathan Ebben, MD, PhD, has the following financial relationship to disclose: • Cofounder, Nano RED The Challenge …
Gastrointestinal Oncology Nataliya Uboha, MD, PhD, Associate Professor University of Wisconsin, Carbone Cancer Center Disclosure of Conflicts of Interest Nataliya Uboha, MD, PhD, has the following financial relationships to disclose: • Consulting: QED, Taiho Inc., Incyte, AstraZeneca, Pfizer, Boston Gene, Helsinn. • Research Funding: Taiho Inc, Ipsen, EMD Serono. • Long position …